Périodique
High-risk behaviors and hospitalizations among gamma hydroxybutyrate (GHB) users
(Comportements à risque élevé et hospitalisations chez les usagers de gamma-hydroxybutyrate (GHB).)
Auteur(s) :
KIM, S. Y. ;
ANDERSON, I. B. ;
DYER, J. E. ;
BARKER, J. C. ;
BLANC, P. D.
Année
2007
Page(s) :
429-438
Langue(s) :
Anglais
Refs biblio. :
21
Domaine :
Drogues illicites / Illicit drugs
Discipline :
EPI (Epidémiologie / Epidemiology)
Thésaurus mots-clés
GHB
;
HOSPITALISATION
;
CONDUITE A RISQUE
;
POLYCONSOMMATION
;
KETAMINE
;
ENQUETE
;
MORBIDITE
Thésaurus géographique
ETATS-UNIS
Note générale :
American Journal of Drug and Alcohol Abuse, 2007, 33, (3), 429-438
Résumé :
INTRODUCTION. Little is known about behaviors linked to gamma hydroxybutyrate (GHB) morbidity. METHODS. We surveyed 131 GHB users, using logistic regression to test the associations between the high risk behaviors and hospital treatment for GHB (26 [20%] of subjects). RESULTS. Increased risk of GHB hospital treatment was associated with: co-ingestion of ethanol (OR 5.2; 95% CI 1.7-16), driving under the influence of GHB (OR 3.2; 95%, CI 1.3-7.8),use of GHB to treat withdrawal symptoms (OR 2.9; 95% CI 1.1-7.9), and co-ingestion of ketamine (OR 2.7; 95% CI 1.1-6.7). CONCLUSION. Targeted prevention activities could focus on selected high-risk behaviors. (Author' s abstract)
Affiliation :
California Poison Control System, Department of Clinical Pharmacy, University of California, San Francisco, CA 94143-1369.
Etats-Unis. United States.
Etats-Unis. United States.
Cote :
A03336
Historique